News

Business Insider4y
Roche launches cobas prime Pre-analytical System, a first-of-its-kind solution designed to automate all common manual steps in molecular diagnostics laboratories
PLEASANTON, Calif., July 30, 2020 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the launch of the cobas® prime Pre-analytical System to improve efficiency in molecular ...
Yahoo Finance10y
Roche's Cobas 6800/8800 Testing Systems Launched
Roche (RHHBY) announced that its cobas 6800/8800 systems – two integrated and fully automated molecular testing systems for blood and plasma donor screening are commercially available in markets ...
Business Insider7y
Roche receives FDA clearance for Factor II and Factor V test on the cobas® 4800 system
PLEASANTON, Calif., Feb. 13, 2018 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it has received FDA clearance for the cobas® Factor II and Factor V Test for use on the ...
Nasdaq6y
Roche receives FDA clearance to expand testing menu on cobas 6800/8800 Systems for sexually transmitted diseases
PLEASANTON, Calif., May 23, 2019 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced US Food and Drug Administration (FDA) 510(k) clearance for the cobas® TV/MG test for use on ...
Yahoo Finance3y
Roche launches cobas 5800, a new molecular diagnostics system to expand access to testing and improve patient care
The cobas 5800 System is a compact new addition to the Roche Molecular portfolio, providing efficiency, simplicity and timely results to laboratories of all sizes so clinicians can quickly ...
News Medical12y
Roche’s cobas 4800 HPV Test receives CE mark
Roche (SIX: RO, ROG; OTCQX: RHHBY) today announces an expanded CE mark indication for the cobas® 4800 HPV Test. The newly expanded indication for the cobas® 4800 HPV Test as a primary screen ...
Nasdaq4y
What's Happening With Roche's Stock?
Roche (OTCMKTS: RHHBY) today announced the launch of the cobas® PIK3CA Mutation Test for patients with advanced or metastatic breast cancer. The company in its press release stated that out of ...
PR Newswire3y
Roche launches the first infectious disease tests and cobas omni Utility Channel for use on the cobas 5800 System in countries accepting the CE Mark
PLEASANTON, Calif., Dec. 15, 2021 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the launch of the first infectious disease tests on the cobas® 5800 System, a new molecular ...
News Medical15y
Roche launches cobas(R) 4800 System in Canada for testing CT, NG and HPV
New cobas(R) 4800 System designed to increase laboratory efficiency and medical value Roche Diagnostics Canada (SIX: RO, ROG; OTCQX: RHHBY) announced today the launch of a new Health Canada ...
Fierce Healthcare13y
Roche Receives FDA Approval for cobas p 630 Pre-analytical Solution for Automated Molecular Testing Platform
Ph.D., Head of Roche Molecular Diagnostics. "Combined with the latest version of our software, the cobas p 630 Instrument helps labs enhance their throughput for a broad menu of important ...
FiercePharma14y
Roche Introduces Immunoassay Module for cobas® 8000 Modular Analyzer Series In U.S.
INDIANAPOLIS, Oct. 29 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the U.S. introduction of the cobas e 602 analyzer, the latest addition to the cobas® 8000 modular analyzer ...
FierceBiotech5y
FDA approves Roche's first cobas test for whole blood donor screening
The cobas Babesia test, for use on the company’s automated cobas 6800/8800 systems, follows an FDA guidance updated earlier this year on testing to reduce the risk of transmitting the parasite ...